TrialPharmacology research & perspectives2024

Pharmacokinetics and pharmacodynamics of the factor XIa-inhibiting antibody osocimab in healthy male East Asian volunteers: Results from two phase 1 studies.

Zhili Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.